ArticleProstate cancer and prostatic diseases2021

Predicting toxicity-related docetaxel discontinuation and overall survival in metastatic castration-resistant prostate cancer: a pooled analysis of open phase 3 clinical trial data.

Alberto Martini et al.PubMed ↗Publisher ↗

No numbers read from the abstract.